In vivo gene delivery mediated by non-viral vectors for cancer therapy

R Mohammadinejad, A Dehshahri… - Journal of Controlled …, 2020 - Elsevier
Gene therapy by expression constructs or down-regulation of certain genes has shown great
potential for the treatment of various diseases. The wide clinical application of nucleic acid …

Nanoparticles as theranostic vehicles in experimental and clinical applications—focus on prostate and breast cancer

J Elgqvist - International journal of molecular sciences, 2017 - mdpi.com
Prostate and breast cancer are the second most and most commonly diagnosed cancer in
men and women worldwide, respectively. The American Cancer Society estimates that …

Silica-based gene delivery systems: From design to therapeutic applications

AM Carvalho, RA Cordeiro, H Faneca - Pharmaceutics, 2020 - mdpi.com
Advances in gene therapy have been foreshadowing its potential for the treatment of a vast
range of diseases involving genetic malfunctioning. However, its therapeutic efficiency and …

Ginsenoside Rg5 attenuates hypoxia‐induced cardiomyocyte apoptosis via regulating the Akt pathway

C Wang, C Huang, J Wang, J Ye, Z Xue… - Chemical Biology & …, 2023 - Wiley Online Library
Ginsenoside Rg5 has been implicated in a variety of diseases. However, it is unknown
whether Ginsenoside Rg5 can protect against hypoxia‐induced neonatal rat cardiomyocytes …

Inorganic nanoparticles for the theranostics of cancer

J Verma, S Lal, CJF Van Noorden - European Journal of …, 2015 - degruyter.com
Theranostics are a multifunctional approach using nanoparticles for combined diagnostic
and therapeutic purposes. The hybrid nanoparticles that are applied for these purposes are …

Cisplatin-functionalized silica nanoparticles for cancer chemotherapy

C Rejeeth, TC Nag, S Kannan - Cancer nanotechnology, 2013 - Springer
Cisplatin is used to treat a variety of tumors, but dose-limiting toxicities or intrinsic and
acquired resistance limit its application in many types of cancer including breast. Cisplatin …

p53 gene therapy of human breast carcinoma: using a transferrin-modified silica nanoparticles

C Rejeeth, S Kannan - Breast Cancer, 2016 - Springer
Background Nanoparticles have an enormous potential for development in biomedical
applications, such as gene or drug delivery. In our study, we examined the efficacy of p53 …

Highly specific colon-targeted transformable capsules containing indomethacin immediate-release pellets for colon cancers therapy

C Yang, Y Zhang, P Cai, S Yuan, Q Ma… - Journal of Drug …, 2020 - Taylor & Francis
Generally, definite intestine targeting and immediate drug releasing are both important for
the treatment of colon cancer via oral administration of anti-cancer drugs. We developed a …

Comparison of two silica based nonviral gene therapy vectors for breast carcinoma: evaluation of the p53 delivery system in Balb/c mice

C Rejeeth, R Vivek - Artificial Cells, Nanomedicine, and …, 2017 - Taylor & Francis
Silica nanoparticles as a nonviral vector for in vivo gene therapy neither surface
functionalized SiNp1 is neither “a cationic ion” nor a surface (encapsulation) nor SiNp2 …

Effect of lipopeptide structure on gene delivery system properties: Evaluation in 2D and 3D in vitro models

OO Koloskova, AM Gileva, MG Drozdova… - Colloids and Surfaces B …, 2018 - Elsevier
Abstract Development of efficient biodegradable, environmentally responsive, biocompatible
and non-toxic delivery system is needed for efficient gene delivery. As well known …